Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASTER: Adjuvant Chemotherapy Regimens in HER2-negative Operable Breast Cancer
NCT01314833Phase 3Completed
- Sponsor
- Fudan University
- Start
- Jun 2010
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in breast cancer, sponsored by Fudan University. Started Jun 2010; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01314833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01314833.